Trial Profile
Clinical Trials Insight: 700028829
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2007
Price :
$35
*
At a glance
- Drugs Volociximab (Primary) ; Doxorubicin
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Biogen; PDL BioPharma
- 27 Nov 2007 New trial record.